An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

Condition:   Recurrent Herpes Labialis Interventions:   Drug: BOR15001L7;   Drug: Docosanol Cream 10% Sponsors:   Laboratoire Boreaderme Inc.;   Ecogene 21 Not yet recruiting

Source: ClinicalTrials.gov - June 6, 2019 Category: Research Source Type: clinical trials